TEVA
Teva Pharmaceutical Industries Ltd. Healthcare - Pharmaceuticals Investor Relations →
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $34.29 as of 2026-05-15, trading 117.5% above its 200-week moving average of $15.76. The stock is currently moving closer to the line, down from 128.6% last week. The 14-week RSI sits at 49, indicating neutral momentum.
Trading volume is running at 1.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.02 ratio) is neutral — neither side is clearly dominating.
Over the past 2260 weeks of data, TEVA has crossed below its 200-week moving average 13 times. On average, these episodes lasted 55 weeks. Historically, investors who bought TEVA at the start of these episodes saw an average one-year return of +21.1%.
With a market cap of $39.9 billion, TEVA is a large-cap stock. The company generates a free cash flow yield of 6.5%, which is healthy. Return on equity stands at 21.6%, indicating strong profitability. The stock trades at 4.8x book value.
Share count has increased 3.5% over three years, indicating dilution.
Over the past 33.4 years, a hypothetical investment of $100 in TEVA would have grown to $1611, compared to $3058 for the S&P 500. TEVA has returned 8.7% annualized vs 10.8% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: TEVA vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After TEVA Crosses Below the Line?
Across 11 historical episodes, buying TEVA when it crossed below its 200-week moving average produced an average return of +18.8% after 12 months (median +16.0%), compared to +17.2% for the S&P 500 over the same periods. 55% of those episodes were profitable after one year. After 24 months, the average return was +60.8% vs +27.3% for the index.
Each line shows $100 invested at the moment TEVA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices TEVA would reach each dislocation threshold.
Dislocation Price Levels
Prices where TEVA's Bean Score would hit each σ threshold. Valid until next earnings report (last report: 2026-03-31).
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $27.45 | Unusually cheap — potential buy zone |
| Value | +1σ | $29.30 | Cheap vs. own history |
| Fair Value | +0σ | $31.43 | Historical mean behavior |
| Expensive | -1σ | $33.88 | Expensive vs. own history |
| Deep Expensive | -2σ | $36.74 | Unusually expensive — potential trim zone |
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Historical Touches
TEVA has crossed below its 200-week MA 13 times with an average 1-year return of +21.1% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jan 1983 | May 1986 | 174 | 81.8% | -72.6% | +10470.9% |
| Jun 1986 | Jul 1986 | 1 | 0.2% | +140.2% | +21041.8% |
| Feb 1998 | Feb 1998 | 2 | 4.3% | +3.4% | +844.2% |
| May 1998 | Jun 1998 | 2 | 1.9% | +21.9% | +777.7% |
| Jun 1998 | Mar 1999 | 39 | 23.7% | +39.0% | +919.9% |
| Jul 2006 | Jul 2006 | 1 | 0.0% | +45.6% | +46.5% |
| Dec 2006 | Jan 2007 | 1 | 1.0% | +52.1% | +39.6% |
| Apr 2011 | May 2011 | 3 | 5.7% | +2.3% | -8.5% |
| Jun 2011 | Jun 2011 | 2 | 1.5% | -18.4% | -13.6% |
| Jul 2011 | Jan 2014 | 131 | 26.0% | -13.8% | -14.5% |
| Sep 2016 | Jan 2023 | 327 | 78.6% | -60.3% | -22.3% |
| Mar 2023 | Jul 2023 | 21 | 23.8% | +49.3% | +276.0% |
| Oct 2023 | Nov 2023 | 7 | 15.1% | +85.7% | +264.0% |
| Average | 55 | — | +21.1% | — |
Frequently Asked Questions
Is TEVA below its 200-week moving average?
No. Teva Pharmaceutical Industries Ltd. (TEVA) is currently 117.5% above its 200-week moving average of $15.76. It would need to fall to $15.76 to cross below the line.
What is TEVA's 200-week moving average price?
Teva Pharmaceutical Industries Ltd.'s 200-week moving average is $15.76 as of 2026-05-15. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when TEVA drops below its 200-week moving average?
TEVA has crossed below its 200-week moving average 13 times in our data. On average, buying at that moment produced a one-year return of +21.1%. These dips have historically been decent entry points. These episodes lasted 55 weeks on average.
Is TEVA a good value right now?
Here's what our data says about TEVA as of 2026-05-15: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 49. Free cash flow yield is 6.5%. Return on equity is 21.6%. Price-to-book is 4.8x. This is not a buy or sell recommendation — always do your own research.
How does TEVA compare to the S&P 500?
Over the past 33.4 years, $100 invested in TEVA would have grown to $1611, compared to $3058 for the S&P 500. That's 8.7% annualized vs 10.8% for the index. TEVA has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-15